Hemolytic uremic syndrome in a developing country: Consensus guidelines

Marie‐Agnès Dragon‐Durey(Assistance Publique – Hôpitaux de Paris), Priyanka Khandelwal(Chacha Nehru Bal Chikitsalaya), Kirtisudha Mishra(Lady Hardinge Medical College), Jyoti Sharma(Bharati Vidyapeeth Deemed University), Arvind Bagga(All India Institute of Medical Sciences), Ranjeet Thergaonkar(Indian Navy), Pankaj Hari(Indian Council of Medical Research), Aditi Sinha, Sidharth Kumar Sethi(Medanta The Medicity), Anil Vasudevan(College of Medicine & JNM Hospital), Saroj Kumar Patnaik(Army Hospital Research and Referral)
Pediatric Nephrology
April 15, 2019
10.1007/s00467-019-04233-7
Cited by 75

Related Papers

Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study
|The Lancet Child & Adolescent Health|2017|722
Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic Syndrome
|Journal of the American Society of Nephrology|2004|415
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|256
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
|Kidney International|2013|216